Cingulate Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cingulate Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $9.14M, a 118.44% increase year-over-year.
- Cingulate Inc. stock issued during period, value, other for the quarter ending 2026-03-31 was $10.14M, a 428.20% increase year-over-year.
- Cingulate Inc. stock issued during period, value, other for the quarter ending 2025-09-30 was $1.46M, a 87.59% decline year-over-year.
- Cingulate Inc. stock issued during period, value, other for the quarter ending 2025-06-30 was $4.18M, a 276.79% increase year-over-year.
- Cingulate Inc. stock issued during period, value, other for fiscal 2025 was $10.15M, a 41.11% decline from fiscal 2024.
- Cingulate Inc. stock issued during period, value, other for fiscal 2024 was $17.24M, a 836.62% increase from fiscal 2023.
- Cingulate Inc. stock issued during period, value, other for fiscal 2023 was $1.84M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $9.14M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.14M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $10.15M 10-K · filed 2026-03-18 | |
| 2025-09-30 | $1.46M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.18M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $1.92M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $17.24M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $11.79M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.11M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $3.12M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $1.84M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.62M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |